{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:27:00Z","timestamp":1783211220533,"version":"3.54.6"},"reference-count":67,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.mrfmmm.2011.07.003","type":"journal-article","created":{"date-parts":[[2011,7,23]],"date-time":"2011-07-23T12:20:12Z","timestamp":1311423612000},"page":"42-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Inactivation of PTEN is responsible for the survival of Hep G2 cells in response to etoposide-induced damage"],"prefix":"10.1016","volume":"715","author":[{"given":"Ananda","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saheli","family":"Samanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parimal","family":"Karmakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0005","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P","article-title":"Estimates of the worldwide incidence of 25 major cancers in 1990","volume":"80","author":"Parkin","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"S19","key":"10.1016\/j.mrfmmm.2011.07.003_bib0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00535-008-2258-6","article-title":"The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology","volume":"44","author":"Caldwell","year":"2009","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0015","first-page":"225","article-title":"Cancer statistics","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0020","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(05)63789-0","article-title":"Increase in primary liver cancer in the UK, 1979\u201394","volume":"350","author":"Taylor-Robinson","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0025","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(05)78179-4","article-title":"Trends in primary liver cancer","volume":"351","author":"Deuffic","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0030","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.4161\/cbt.4.12.2422","article-title":"Capitalizing on AKT signaling to inhibit hepatocellular carcinoma cell proliferation","volume":"4","author":"Singh","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-3835(98)00280-8","article-title":"The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line","volume":"135","author":"Huang","year":"1999","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0040","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/MEG.0b013e3283378405","article-title":"Unfolded protein response activation contributes to chemoresistance in hepatocellular carcinoma","volume":"22","author":"Al-Rawashdeh","year":"2010","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1476-4598-7-27","article-title":"Hypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activity","volume":"7","author":"Sermeus","year":"2008","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0050","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4161\/auto.5.8.9996","article-title":"Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells","volume":"5","author":"Song","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0055","doi-asserted-by":"crossref","first-page":"10983","DOI":"10.1073\/pnas.211430998","article-title":"AKT plays a central role in tumorigenesis","volume":"98","author":"Testa","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0060","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0092-8674(95)90534-0","article-title":"The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase","volume":"81","author":"Franke","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","article-title":"Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha","volume":"7","author":"Alessi","year":"1997","journal-title":"Curr. Biol."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0070","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.89.19.9267","article-title":"AKT2, a putative oncogene encoding a member of a subfamily of protein-serine\/threonine kinases, is amplified in human ovarian carcinomas","volume":"89","author":"Cheng","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0075","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1073\/pnas.93.8.3636","article-title":"Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA","volume":"93","author":"Cheng","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0080","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ijc.23049","article-title":"Phosphoinositide 3-kinase\/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death","volume":"122","author":"Yu","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11670-002-0036-1","article-title":"Overexpression of Akt-1 gene in human hepatocellular carcinoma","volume":"14","author":"Liu","year":"2002","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0090","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1158\/0008-5472.CAN-08-0257","article-title":"Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells","volume":"68","author":"Chen","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0095","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1158\/1078-0432.CCR-08-2878","article-title":"Activation of phosphatidylinositol-3\u2032-kinase\/AKT signaling is essential in hepatoblastoma survival","volume":"15","author":"Hartmann","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.21467","article-title":"Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets","volume":"45","author":"Boyault","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0105","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1038\/sj.onc.1202659","article-title":"PTEN\/MMAC1 mutations in hepatocellular carcinomas","volume":"18","author":"Yao","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0110","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/cncr.11266","article-title":"Expression and prognostic role of tumor suppressor gene PTEN\/MMAC1\/TEP1 in hepatocellular carcinoma","volume":"97","author":"Hu","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0115","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1872-034X.2007.00042.x","article-title":"Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma","volume":"37","author":"Wang","year":"2007","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0125","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/carcin\/bgq085","article-title":"PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells: PTEN regulates angiogenesis in HepG2","volume":"31","author":"Tian","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0130","first-page":"1593","article-title":"PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K\/Akt pathway","volume":"23","author":"Tian","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0135","first-page":"45","article-title":"Correlation between loss of PTEN expression and PKB\/AKT phosphorylation in hepatocellular carcinoma","volume":"25","author":"Yang","year":"2005","journal-title":"Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0140","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1172\/JCI20513","article-title":"Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas","volume":"113","author":"Horie","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0145","first-page":"105","article-title":"Molecular genetics of hepatocellular neoplasia","volume":"23","author":"Jain","year":"2010","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.etp.2009.11.005","article-title":"Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt\/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells","volume":"63","author":"Parekh","year":"2011","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0155","first-page":"7457","article-title":"Production of interleukin 6 from human liver cell lines: production of interleukin 6 is not concurrent with the production of \u03b1-fetoprotein","volume":"50","author":"Matsuguchi","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0160","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.tiv.2009.05.018","article-title":"Caffeine augments Alprazolam induced cytotoxicity in human cell lines","volume":"23","author":"Saha","year":"2009","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0170","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/jnci\/80.19.1526","article-title":"Mechanism of action of antitumor drug etoposide: a review","volume":"80","author":"van Maanen","year":"1988","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0175","doi-asserted-by":"crossref","first-page":"29238","DOI":"10.1074\/jbc.271.46.29238","article-title":"Topoisomerase II.etoposide interactions direct the formation of drug-induced enzyme-DNA cleavage complexes","volume":"271","author":"Burden","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mrfmmm.2008.03.005","article-title":"Assessment of DNA double-strand breaks and gammaH2AX induced by the topoisomerase II poisons etoposide and mitoxantrone","volume":"641","author":"Smart","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0185","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1096\/fasebj.10.2.8641557","article-title":"DNA damage and cell cycle checkpoints","volume":"10","author":"Kaufmann","year":"1996","journal-title":"FASEB J."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0190","doi-asserted-by":"crossref","first-page":"15209","DOI":"10.1073\/pnas.93.26.15209","article-title":"DNA damage and p53-mediated cell cycle arrest: a reevaluation","volume":"93","author":"Pellegata","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0195","first-page":"4074","article-title":"G2 arrest in response to topoisomerase II inhibitors: the role of p53","volume":"63","author":"Clifford","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0200","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature03097","article-title":"Cell-cycle checkpoints and cancer","volume":"432","author":"Kastan","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0205","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrc1011","article-title":"ATM and related protein kinases: safeguarding genome integrity","volume":"3","author":"Shiloh","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0210","doi-asserted-by":"crossref","first-page":"48627","DOI":"10.1074\/jbc.C100556200","article-title":"Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex","volume":"276","author":"Vazquez","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0215","doi-asserted-by":"crossref","first-page":"23306","DOI":"10.1074\/jbc.M611240200","article-title":"Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain","volume":"282","author":"Odriozola","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0220","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1073\/pnas.0812473106","article-title":"Phosphorylation keeps PTEN phosphatase closed for business","volume":"106","author":"Ross","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0225","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1042\/bj3370083","article-title":"Changes in polyamine catabolism in HL-60 human promyelogenous leukaemic cells in response to etoposide-induced apoptosis","volume":"337","author":"Lindsay","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0230","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.cdd.4400595","article-title":"The topoisomerase inhibitors camptothecin and etoposide induce a CD95-independent apoptosis of activated peripheral lymphocytes","volume":"7","author":"Ferraro","year":"2000","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0235","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1476-4598-6-61","article-title":"Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines","volume":"6","author":"Cosse","year":"2007","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0240","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cncr.20774","article-title":"Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma","volume":"103","author":"Nakanishi","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0245","doi-asserted-by":"crossref","first-page":"7831","DOI":"10.1128\/MCB.22.22.7831-7841.2002","article-title":"Activation of Akt\/protein kinase B overcomes a G(2)\/M cell cycle checkpoint induced by DNA damage","volume":"22","author":"Kandel","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0250","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1182\/blood.V98.3.834","article-title":"DNA damage-induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase\/Akt signaling pathway","volume":"98","author":"Henry","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0255","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00432-004-0613-4","article-title":"Genomic instability in hepatocellular carcinoma revealed by using the random amplified polymorphic DNA method","volume":"130","author":"Zhang","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0260","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1073\/pnas.0305817101","article-title":"Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma","volume":"101","author":"Wilkens","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0265","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc2842","article-title":"Phosphoinositide signalling in cancer: beyond PI3K and PTEN","volume":"10","author":"Bunney","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0270","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1002\/j.1460-2075.1996.tb01045.x","article-title":"Mechanism of activation of protein kinase B by insulin and IGF-1","volume":"15","author":"Alessi","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0275","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1634\/theoncologist.11-7-790","article-title":"Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?","volume":"11","author":"Zhu","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0280","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2174\/156801105774574649","article-title":"Inhibition of PI3K\/Akt signaling: an emerging paradigm for targeted cancer therapy","volume":"5","author":"Chen","year":"2005","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0285","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1248\/bpb.30.1624","article-title":"PTEN: its deregulation and tumorigenesis","volume":"30","author":"Maehama","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0290","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1074\/jbc.M009134200","article-title":"The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation","volume":"276","author":"Torres","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0295","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1073\/pnas.0510570103","article-title":"Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane","volume":"103","author":"Vazquez","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0300","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ncb1236","article-title":"Regulation of PTEN by Rho small GTPases","volume":"7","author":"Li","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0305","doi-asserted-by":"crossref","first-page":"35195","DOI":"10.1074\/jbc.M503045200","article-title":"Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3beta","volume":"280","author":"Al-Khouri","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0310","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1073\/pnas.0908899107","article-title":"Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase","volume":"107","author":"Chagpar","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0315","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4049\/jimmunol.169.1.286","article-title":"Negative feedback regulation of the tumor suppressor PTEN by phosphoinositide-induced serine phosphorylation","volume":"169","author":"Birle","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0320","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-5793(02)03274-X","article-title":"Direct identification of PTEN phosphorylation sites","volume":"528","author":"Miller","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0325","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(00)81780-8","article-title":"Negative regulation of PKB\/Akt-dependent cell survival by the tumor suppressor PTEN","volume":"95","author":"Stambolic","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0330","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1086\/340026","article-title":"Protean PTEN: form and function","volume":"70","author":"Waite","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mrfmmm.2011.07.003_bib0335","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ygyno.2005.12.033","article-title":"Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner","volume":"102","author":"Yan","year":"2006","journal-title":"Gynecol. Oncol."}],"container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510711001795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510711001795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T13:26:02Z","timestamp":1764595562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027510711001795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":67,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0027510711001795"],"URL":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2011.07.003","relation":{},"ISSN":["1386-1964"],"issn-type":[{"value":"1386-1964","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inactivation of PTEN is responsible for the survival of Hep G2 cells in response to etoposide-induced damage","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2011.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}